SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy is experiencing a period of intense volatility and selling pressure, which traders attribute to a combination of share lockup expirations following a recent acquisition, analyst price target adjustments, and broader market de-risking in energy-related assets. Despite this downward price action, many participants remain bullish on the long-term thesis, citing the company's critical role in providing baseload nuclear power for AI data centers and its recent long-term power purchase agreements.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

The discussion remains fragmented as traders debate long-term potential amid a prolonged price decline, with many expressing frustration over the lack of upward momentum despite project developments. Some community members view current price levels as an accumulation opportunity, while others dismiss the asset as a poor investment.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is receiving attention following reports that it proactively pulled jalapeños from some locations due to a potential link to a salmonella outbreak in Minnesota. While some traders are expressing concern over the potential for negative headlines to impact brand trust and sales, others view the pullback as a buying opportunity, noting the company's quick response and confirmation from health officials that there is no ongoing risk.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is trending as investors debate its long-term viability, focusing on high cash burn rates, management's historical performance, and the potential for dilution despite positive revenue growth and recent technological advancements. Sentiment remains polarized, with bulls pointing to the commercial potential of the Eversense 365 system and institutional accumulation, while bears emphasize a history of reverse splits and concerns over operational execution.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Helium is experiencing significant volatility as the community debates its long-term viability, with some traders citing potential short squeeze opportunities and adoption in city-wide network projects, while others express concerns over supply inflation, network utility, and past management decisions.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies is trending as investors react to strong quarterly earnings, where the company exceeded revenue and backlog estimates, alongside ongoing optimism surrounding its defense contracts and lunar infrastructure initiatives. While the community shows enthusiasm for its growth potential as a space and defense play, some traders expressed frustration over recent volatility and price underperformance compared to the broader space sector.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is trending following a significant analyst upgrade and institutional accumulation, with market participants closely monitoring the upcoming CVS Caremark formulary decision and competitive dynamics with Aquestive Therapeutics. Discussions remain divided between those anticipating a major short squeeze and near-term catalysts, and others expressing skepticism regarding the company's high cash burn, aggressive spending, and long-term commercial execution.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol Myers Squibb is receiving attention due to the positive Phase 3 SUCCESSOR-2 results for its mezigdomide combination in multiple myeloma and ongoing optimism surrounding its growth portfolio. Investors are also monitoring the impact of recent AI-driven partnerships on pipeline development as the company works to offset revenue pressure from legacy patent cliffs.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

The community discussion remains heavily fragmented, oscillating between frustration over prolonged price underperformance and high-conviction support for the network's decentralized cloud and AI infrastructure. Supporters emphasize the long-term utility of the project's technical developments, such as the Caffeine AI platform and sovereign cloud initiatives, while detractors frequently dismiss the asset as a failing, over-diluted project.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

The community discussion remains heavily focused on the long-term utility of the Zebec SuperApp, with traders debating whether mobile adoption will successfully drive recurring token demand, staking, and the buyback program. While many investors are using price pullbacks as an opportunity to accumulate tokens, there is clear disagreement and frustration regarding the project's price performance and the lack of immediate market reaction to past partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BCRX is trending as investors debate ongoing buyout speculation, the company's strategic pivot away from internal discovery to an external innovation model, and the potential impact of future pipeline readouts. Community sentiment remains divided between frustration over historical price performance and optimism regarding the long-term value of its HAE franchise.

Is BioCryst Pharmaceuticals (BCRX) Stock Outpacing Its Medical Peers This Year?

Here is how BioCryst Pharmaceuticals (BCRX) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.

BioCryst’s Orladeyo Built The Cash Pile, CEO Gayer Wants To Buy The Next Asset

Equity

CEO Gayer told CNBC in an interview that the company is now profitable and plans to use that cash to invest in other rare-disease medicines.

Wall Street Analysts Think BioCryst (BCRX) Could Surge 108.21%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 108.2% in BioCryst (BCRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts See a 98.74% Upside in BioCryst (BCRX): Can the Stock Really Move This High?

The consensus price target hints at a 98.7% upside potential for BioCryst (BCRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Implied Volatility Surging for BioCryst Pharmaceuticals Stock Options

Investors need to pay close attention to BCRX stock based on the movements in the options market lately. 

BioCryst Bets On Rare Genetic Disorder Therapy Expansion Amid Q2 Earnings Beat – Retail Piles On Buyout Speculation

BioCryst raised its full-year 2026 total revenue outlook to $690 million to $715 million, up from its previous estimates of $635 million to $660 million.

BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of +114.29% and +18.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Biocryst Pharmaceuticals Inc Q2 Profit Climbs

(RTTNews) - Biocryst Pharmaceuticals Inc (BCRX) released earnings for its second quarter that Increased, from the same period last year...

Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower 

Drugmakers have announced 37 biotech acquisitions worth at least $1 billion this year, topping the previous annual record.

BioCryst Pharmaceuticals Appoints David Jenkins As Chief Scientific Officer

(RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX) said on Wednesday that it has appointed David W. Jenkins to the newly created role of Chief Scientific Officer with immediate effect...

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.09	--	--	N/A
Q2 '26	$0.15	$0.30	94.58%	BEAT
Q1 '26	$0.04	-$2.98	-6831.88%	MISSED
Q4 '25	$0.05	$1.12	2220.04%	BEAT
Q3 '25	$0.04	$0.06	50.75%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

BCRX Earnings

Upcoming Earnings: Q3 '26

Historical Earnings